Neurizon Therapeutics (ASX:NUZ) - Key People
ASX:NUZ · Directors, executives and key personnel · 12 month lookback
Mr Sergio Duchini
Current
Executive Chair (Executive Chairman)
Mentioned in
Healthcare Wrap - Week 37 (7 Sept -> 11 Sept) 2026
12 Sept 2026
Neurizon Cuts Convertible Note Exposure in US$1.15 Million Obsidian Deal
10 Sept 2026
Neurizon Names Global Pharma Executive Chris Bremer as CEO Ahead of ALS Results
7 Sept 2026
Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026
29 Aug 2026
Michael Thurn
Former
Departed Oct 2026
Mentioned in
Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026
29 Aug 2026
Neurizon Therapeutics Advances ALS Trial and Strengthens Financial Position in FY2026
25 Aug 2026
Healthcare Wrap - Week 12 (16 Mar -> 20 Mar) 2026
21 Mar 2026
Neurizon CEO Steps Down as Interim Chair Takes Helm Amid Global Search
16 Mar 2026
Also Mentioned
People named in Neurizon Therapeutics (ASX:NUZ) articles over the last 12 months, by frequency.
Henry Jordan
· 16 articles
Lidija Damjanovic
· 13 articles
Merit Cudkowicz
· 5 articles
Matthew Selinger
· 5 articles
Marcus Hughes
· 4 articles
Katie MacFarlane
· 4 articles
Justine Conway
· 4 articles
Sergio Duchini, Interim Executive Chairman of Neurizon Therapeutics
· 3 articles
Sabrina Paganoni, Healey & AMG Center for ALS
· 3 articles
Lidija Damjanovic, Neurizon Therapeutics
· 3 articles
Henry Jordan, Six Degrees Investor Relations
· 3 articles
Professor Merit Cudkowicz
· 3 articles
Dan O’Connell
· 3 articles
Ross Murdoch
· 2 articles
Daniel O'Connell
· 2 articles
Sabrina Paganoni
· 2 articles
Stefan Ross
· 2 articles
Jeffrey M. Brown
· 2 articles
Sharon Tamir
· 2 articles
John Clark
· 1 article